US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lexeo Therapeutics

3.21

+0.500018.45%

Post-market: 3.16-0.0499-1.55%18:16 EDT

Volume:1.06M

Turnover:3.28M

Market Cap:106.56M

PE:-1.04

High:3.27

Open:2.69

Low:2.62

Close:2.71

Loading ...

Overview Company News Filings

Lexeo Therapeutics Inc - Q4 Loss per Share $0.78

THOMSON REUTERS

Lexeo Therapeutics Q4 2024 GAAP EPS $(0.78) Vs. $(0.86) YoY, Cash, Cash Equivalents And Investments Of $128.5M Expected To Provide Operational Runway Into 2027

Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Top Executives at Lexeo Therapeutics Cash In on Stock Sales!

Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from Stifel Nicolaus

Lexeo Therapeutics Price Target Maintained With a $24.00/Share by RBC Capital

BRIEF-Lexeo Therapeutics Appoints Kyle Rasbach As CFO

Lexeo Therapeutics Appoints Dr. Kyle Rasbach as CFO

Lexeo Therapeutics Names Kyle Rasbach Chief Financial Officer

Lexeo Therapeutics appoints Rasbach as Chief Financial Officer

Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

THOMSON REUTERS

Press Release: Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer

Lexeo Therapeutics Files $300 Million Mixed Shelf Registration

MT Newswires Live

Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics

Simply Wall St.

Lexeo Therapeutics’ Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity

Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report

Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital

Lexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/LXEO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LXEO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXEO\",,,,,undefined,":{"symbol":"LXEO","market":"US","secType":"STK","nameCN":"Lexeo Therapeutics","latestPrice":3.21,"timestamp":1745265600000,"preClose":2.71,"halted":0,"volume":1064339,"hourTrading":{"tag":"盘后","latestPrice":3.1601,"preClose":3.21,"latestTime":"18:16 EDT","volume":2227,"amount":7142.9655395,"timestamp":1745273785088},"delay":0,"floatShares":21795584,"shares":33196997,"eps":-3.093449,"marketStatus":"Post-Mkt","change":0.5,"latestTime":"04-21 18:26:27 EDT","open":2.69,"high":3.265,"low":2.6209,"amount":3280213.3983106,"amplitude":0.237675,"askPrice":3.2,"askSize":20,"bidPrice":3.19,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-3.093449,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"listingDate":1698984000000,"exchange":"NASDAQ","adjPreClose":2.71,"preHourTrading":{"tag":"盘前","latestPrice":2.71,"preClose":2.71,"latestTime":"09:25 EDT","volume":1528,"amount":4039.847112,"timestamp":1745241900039},"postHourTrading":{"tag":"盘后","latestPrice":3.1601,"preClose":3.21,"latestTime":"18:16 EDT","volume":2227,"amount":7142.9655395,"timestamp":1745273785088},"volumeRatio":1.547333,"impliedVol":1.2555,"impliedVolPercentile":0.427},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LXEO\",,,,,undefined,":{"symbol":"LXEO","floatShares":21795584,"roa":"-46.11%","roe":"-85.37%","lyrEps":-3.093449,"volumeRatio":1.547333,"shares":33196997,"dividePrice":0,"high":3.265,"amplitude":0.237675,"preClose":2.71,"low":2.6209,"week52Low":1.45,"pbRate":"0.91","week52High":19.5,"institutionHeld":0,"latestPrice":3.21,"committee":0.935484,"eps":-3.093449,"divideRate":0,"volume":1064339,"delay":0,"ttmEps":-3.093449,"open":2.69,"prevYearClose":6.58,"prevWeekClose":2.71,"prevMonthClose":3.47,"prevQuarterClose":3.47,"fiveDayClose":1.98,"twentyDayClose":2.71,"sixtyDayClose":5.61},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LXEO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2521746765","title":"Lexeo Therapeutics Inc - Q4 Loss per Share $0.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746765?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:10","pubTimestamp":1742814659,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250324:nFWN3Q70V7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2521746739","title":"Lexeo Therapeutics Q4 2024 GAAP EPS $(0.78) Vs. $(0.86) YoY, Cash, Cash Equivalents And Investments Of $128.5M Expected To Provide Operational Runway Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746739","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746739?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:10","pubTimestamp":1742814656,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics (NASDAQ:LXEO) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.79) by 1.27 percent. This is a 9.3 percent increase over losses of $(0.86) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44454695/lexeo-therapeutics-q4-2024-gaap-eps-0-78-vs-0-86-yoy-cash-cash-equivalents-and-investments-of-128-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO"],"gpt_icon":0},{"id":"2521746991","title":"Lexeo Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2521746991","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521746991?lang=en_us&edition=fundamental","pubTime":"2025-03-24 19:00","pubTimestamp":1742814000,"startTime":"0","endTime":"0","summary":"Additional alignment with FDA on LX2006 planned pivotal study including protein expression co-primary endpoint: based on improvements in LVMI across participants with abnormal LVMI at baseline, frataxin expression to be evaluated for any increase from baseline rather than numerical threshold. Interim update from cohort 1 of LX2020 HEROIC-PKP2 Phase 1/2 trial: observed 71% and 115% increases in PKP2 protein expression in first two post-treatment biopsies; first participant evaluated 6-months after dosing experienced 67% reduction in premature ventricular contractions . Completed enrollment of cohort 2 of LX2020 HEROIC-PKP2 Phase 1/2 trial; interim clinical data update expected in second half of 2025. LX2020 has been generally well tolerated with no treatment-related serious adverse events to date. Cash, cash equivalents and investments of $128.5 million expected to provide operational runway into 2027. NEW YORK, March 24, 2025  -- Lexeo Therapeutics, Inc. , a clinical stage genetic medi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lexeo-therapeutics-reports-fourth-quarter-110000124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LXEO","BK4535","BK4539","FA","BK4130"],"gpt_icon":0},{"id":"2520889517","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520889517","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520889517?lang=en_us&edition=fundamental","pubTime":"2025-03-17 18:00","pubTimestamp":1742205600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RWAY","RBOT","CBUS","LXEO","BTM","NOA","OSS","SPRY","STNE","INO","AEVA","CELC","ABSI","STTK","CMC","DERM","PHUN","IMTX","BLTE","KOPN","FLUX","LQDA","PL","KLC","LPRO","ASO","SGMO","CNTX","BCAB","DMAC","FIVE","LEN.B","SCPH","LAR","HYPR","SIG","OPTN","LVTX","ANRO","DRI","OABI","MSIF","NRXP","RANI","AUTL","GLUE","CAL","SAIC"],"gpt_icon":1},{"id":"2519876572","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2519876572","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519876572?lang=en_us&edition=fundamental","pubTime":"2025-03-14 18:00","pubTimestamp":1741946400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bitcoin Depot Inc.                               4Q       .02   8:05 AM. ·IHS Hldg Ltd.                                    4Q       .01   6:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INKT","HROW","KOPN","MBRX","ACN","LQDA","CAPR","LE","IDN","LVTX","AEVA","RLYB","ERAS","FDX","NKTX","CNTX","LPRO","LAR","PRSO","RANI","NRXP","GOGO","INSE","OSS","STNE","CAL","DRI","HTHT","HYPR","MRC","TYRA","GANX","SPRY","IFRX","JILL","DTI","FDS","LXEO","MGNX","AMPX","TME","PL","GIS","AUTL","ABSI","DTIL","ANRO"],"gpt_icon":1},{"id":"2513240584","title":"Top Executives at Lexeo Therapeutics Cash In on Stock Sales!","url":"https://stock-news.laohu8.com/highlight/detail?id=2513240584","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513240584?lang=en_us&edition=fundamental","pubTime":"2025-02-22 10:07","pubTimestamp":1740190065,"startTime":"0","endTime":"0","summary":"New insider activity at Lexeo Therapeutics, Inc. ( ($LXEO) ) has taken place on February 22, 2025. In recent transactions involving Lexeo Therapeut...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executives-at-lexeo-therapeutics-cash-in-on-stock-sales?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executives-at-lexeo-therapeutics-cash-in-on-stock-sales?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO"],"gpt_icon":0},{"id":"2510851153","title":"Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2510851153","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510851153?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:46","pubTimestamp":1739191588,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Matteis from Stifel Nicolaus maintained a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report), with a ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO","SF","BK4139","BK4127"],"gpt_icon":0},{"id":"2505920151","title":"Lexeo Therapeutics Price Target Maintained With a $24.00/Share by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2505920151","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505920151?lang=en_us&edition=fundamental","pubTime":"2025-01-22 01:23","pubTimestamp":1737480180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LXEO/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 21, 2025 12:23 ET (17:23 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO"],"gpt_icon":0},{"id":"2492200124","title":"BRIEF-Lexeo Therapeutics Appoints Kyle Rasbach As CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2492200124","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492200124?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:36","pubTimestamp":1734611812,"startTime":"0","endTime":"0","summary":"BRIEF-Lexeo Therapeutics Appoints Kyle Rasbach As CFODec 19 (Reuters) - Lexeo Therapeutics Inc LXEO.O:LEXEO THERAPEUTICS APPOINTS KYLE RASBACH AS CHIEF FINANCIAL OFFICERSource text: ID:nGNX8RbwrQFurther company coverage: LXEO.O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA3GWDWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2492124143","title":"Lexeo Therapeutics Appoints Dr. Kyle Rasbach as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2492124143","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492124143?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:28","pubTimestamp":1734611304,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Lexeo Therapeutics, Inc. ( ($LXEO) ). Lexeo Therapeutics has appointed Dr. Kyle Rasbach as the new Chief Financ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lexeo-therapeutics-appoints-dr-kyle-rasbach-as-cfo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lexeo-therapeutics-appoints-dr-kyle-rasbach-as-cfo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2492433121","title":"Lexeo Therapeutics Names Kyle Rasbach Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492433121","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492433121?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:18","pubTimestamp":1734610680,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics has hired Kyle Rasbach as chief financial officer of the clinical-stage genetic-medicine company.Lexeo on Thursday said Rasbach, 44 years old, most recently served as chief business officer at Zentalis Pharmaceuticals.The New York company said Rasbach will receive an initial annual base salary of $480,000 and a discretionary annual bonus with a target of up to 40% of his annualized salary for the preceding calendar year.R. Nolan Townsend, Lexeo's chief executive, had been serving as the company's principal financial officer.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2492920121","title":"Lexeo Therapeutics appoints Rasbach as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492920121","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492920121?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:06","pubTimestamp":1734609969,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics (LXEO) announced that Dr. Kyle Rasbach has been appointed Chief Financial Officer, CFO, effective immediately. Most recently, Dr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-appoints-rasbach-as-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-appoints-rasbach-as-chief-financial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2492198129","title":"Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492198129","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492198129?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241219:nTUA3GWDWB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LXEO","BK4139"],"gpt_icon":0},{"id":"2492291321","title":"Press Release: Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2492291321","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492291321?lang=en_us&edition=fundamental","pubTime":"2024-12-19 20:00","pubTimestamp":1734609600,"startTime":"0","endTime":"0","summary":"NEW YORK, Dec. 19, 2024  -- Lexeo Therapeutics, Inc. , a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer's disease, today announced that Dr. Kyle Rasbach has been appointed Chief Financial Officer, effective immediately. Dr. Rasbach brings a wealth of life sciences experience to the company and joins ahead of multiple anticipated catalysts across its gene therapy programs.\"Kyle has an exceptional track record as an operator and life sciences portfolio manager, and we are excited to welcome him to Lexeo at a time when we are advancing our pipeline and transitioning towards pivotal studies,\" said R. Nolan Townsend, Chief Executive Officer of Lexeo Therapeutics. \"His experience in strategic planning, financial management and business development, combined with his scientific background, will complement our management team and support Lexeo's continued growth into 2025.\". Lexeo Therape","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2491716213","title":"Lexeo Therapeutics Files $300 Million Mixed Shelf Registration","url":"https://stock-news.laohu8.com/highlight/detail?id=2491716213","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491716213?lang=en_us&edition=fundamental","pubTime":"2024-12-13 23:29","pubTimestamp":1734103783,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics  filed a registration statement Friday with the US Securities and Exchange Commission for the potential sale of up to $300 million of its securities via one or more offerings.The registration covers common stock, preferred stock, debt securities, warrants, subscription rights, purchase contracts, and units, according to the filing.The company said it will outline how it plans to use the proceeds from the sale of securities in a prospectus supplement.Price: 7.12, Change: -0.01, Percent Change: -0.14","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2486139150","title":"Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2486139150","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486139150?lang=en_us&edition=fundamental","pubTime":"2024-11-28 18:18","pubTimestamp":1732789083,"startTime":"0","endTime":"0","summary":"Potential Lexeo Therapeutics, Inc.  shareholders may wish to note that the Independent Director, Paula H. Cholmondeley, recently bought US$105k worth of stock, paying US$6.99 for each share. We reckon that's a good sign, especially since the purchase boosted their holding by 96%.The Last 12 Months Of Insider Transactions At Lexeo Therapeutics. In fact, the recent purchase by Paula H. Cholmondeley was the biggest purchase of Lexeo Therapeutics shares made by an insider individual in the last twelve months, according to our records. Even though the purchase was made at a significantly lower price than the recent price , we still think insider buying is a positive. Because the shares were purchased at a lower price, this particular buy doesn't tell us much about how insiders feel about the current share price.You can see a visual depiction of insider transactions  over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share pr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/paula-h-cholmondeley-bought-96-101803558.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2485897434","title":"Lexeo Therapeutics’ Promising Gene Therapy Progress and Strong Financial Position Present Attractive Investment Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2485897434","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485897434?lang=en_us&edition=fundamental","pubTime":"2024-11-21 14:36","pubTimestamp":1732170979,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics, Inc. (LXEO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Brian S...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-promising-gene-therapy-progress-and-strong-financial-position-present-attractive-investment-opportunity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-promising-gene-therapy-progress-and-strong-financial-position-present-attractive-investment-opportunity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRGS","LU2065732104.USD","LXEO","BK4139","BK4097"],"gpt_icon":0},{"id":"2483394246","title":"Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2483394246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483394246?lang=en_us&edition=fundamental","pubTime":"2024-11-15 12:35","pubTimestamp":1731645327,"startTime":"0","endTime":"0","summary":"Lexeo Therapeutics, Inc. ( ($LXEO) ) has released its Q3 earnings. Here is a breakdown of the information Lexeo Therapeutics, Inc. presented to its...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lexeo-therapeutics-advances-cardiac-portfolio-amid-financial-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lexeo-therapeutics-advances-cardiac-portfolio-amid-financial-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LXEO"],"gpt_icon":0},{"id":"2483626463","title":"Lexeo Therapeutics, Inc. (LXEO) Gets a Buy from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2483626463","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483626463?lang=en_us&edition=fundamental","pubTime":"2024-11-15 09:48","pubTimestamp":1731635331,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Luca Issi maintained a Buy rating on Lexeo Therapeutics, Inc. (LXEO – Research Report) on November 13 and set a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-rbc-capital?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/lexeo-therapeutics-inc-lxeo-gets-a-buy-from-rbc-capital?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO","BK4139","BK4207"],"gpt_icon":0},{"id":"2483587830","title":"Lexeo Therapeutics price target raised to $23 from $21 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2483587830","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483587830?lang=en_us&edition=fundamental","pubTime":"2024-11-14 19:16","pubTimestamp":1731582967,"startTime":"0","endTime":"0","summary":"H.C. Wainwright raised the firm’s price target on Lexeo Therapeutics (LXEO) to $23 from $21 and keeps a Buy rating on the shares after alignment wa...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-price-target-raised-to-23-from-21-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lexeo-therapeutics-price-target-raised-to-23-from-21-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LXEO"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":60,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LXEO\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LXEO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LXEO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1718251200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LXEO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LXEO","date":"2025-04-17","current":-0.769723,"percent":0.985423,"low":-8.903248,"twenty":-6.30019,"median":-4.649906,"eighty":-2.355198,"high":-0.6043,"avg":-4.462675,"sd":2.064581,"marketCap":75689153},"quantilePoints":[{"date":"2023-11-03","current":-4.257819,"twenty":-4.257819,"median":-4.257819,"eighty":-4.257819,"marketCap":271355051},{"date":"2023-11-10","current":-4.199758,"twenty":-4.199758,"median":-4.091377,"eighty":-4.048799,"marketCap":267654754},{"date":"2023-11-17","current":-4.292656,"twenty":-4.257819,"median":-4.118472,"eighty":-4.064282,"marketCap":273575228},{"date":"2023-11-24","current":-4.373941,"twenty":-4.270979,"median":-4.199758,"eighty":-4.070475,"marketCap":278755643},{"date":"2023-12-01","current":-4.923587,"twenty":-4.377038,"median":-4.259754,"eighty":-4.081313,"marketCap":313785113},{"date":"2023-12-08","current":-5.031968,"twenty":-4.945263,"median":-4.26556,"eighty":-4.111505,"marketCap":320692333},{"date":"2023-12-15","current":-4.58828,"twenty":-4.855461,"median":-4.333298,"eighty":-4.161824,"marketCap":306423687},{"date":"2023-12-22","current":-5.849059,"twenty":-5.408075,"median":-4.389424,"eighty":-4.194339,"marketCap":390623587},{"date":"2023-12-29","current":-5.805172,"twenty":-5.505138,"median":-4.537237,"eighty":-4.207282,"marketCap":387692577},{"date":"2024-01-05","current":-5.857039,"twenty":-5.805172,"median":-4.621669,"eighty":-4.218567,"marketCap":391156497},{"date":"2024-01-12","current":-5.896937,"twenty":-5.857039,"median":-4.799136,"eighty":-4.257819,"marketCap":393821051},{"date":"2024-01-19","current":-6.012642,"twenty":-5.955803,"median":-4.957419,"eighty":-4.257819,"marketCap":401548257},{"date":"2024-01-26","current":-6.66298,"twenty":-6.148663,"median":-5.403559,"eighty":-4.260916,"marketCap":444980484},{"date":"2024-02-02","current":-6.706868,"twenty":-6.322251,"median":-5.468033,"eighty":-4.26169,"marketCap":447911493},{"date":"2024-02-09","current":-6.714848,"twenty":-6.590366,"median":-5.777243,"eighty":-4.264786,"marketCap":448444404},{"date":"2024-02-16","current":-6.072489,"twenty":-6.589568,"median":-5.827115,"eighty":-4.287237,"marketCap":405545088},{"date":"2024-02-23","current":-6.343796,"twenty":-6.544084,"median":-5.876988,"eighty":-4.341427,"marketCap":423664054},{"date":"2024-03-01","current":-5.8331,"twenty":-6.543286,"median":-5.916886,"eighty":-4.373941,"marketCap":389557765},{"date":"2024-03-08","current":-5.857039,"twenty":-6.520145,"median":-5.890953,"eighty":-4.383231,"marketCap":391156497},{"date":"2024-03-15","current":-6.292966,"twenty":-6.520145,"median":-5.916886,"eighty":-4.447485,"marketCap":417815207},{"date":"2024-03-22","current":-6.028084,"twenty":-6.505782,"median":-5.977118,"eighty":-4.547445,"marketCap":400228597},{"date":"2024-03-28","current":-6.128418,"twenty":-6.497802,"median":-5.937219,"eighty":-4.601636,"marketCap":406890192},{"date":"2024-04-05","current":-5.265543,"twenty":-6.474661,"median":-5.932845,"eighty":-4.625869,"marketCap":349600479},{"date":"2024-04-12","current":-5.241463,"twenty":-6.410602,"median":-5.90231,"eighty":-4.683238,"marketCap":348001696},{"date":"2024-04-19","current":-4.844139,"twenty":-6.359022,"median":-5.876988,"eighty":-4.791277,"marketCap":321621782},{"date":"2024-04-26","current":-4.88026,"twenty":-6.350977,"median":-5.858281,"eighty":-4.83704,"marketCap":324019956},{"date":"2024-05-03","current":-6.182772,"twenty":-6.32828,"median":-5.876988,"eighty":-4.840714,"marketCap":410498948},{"date":"2024-05-10","current":-6.881509,"twenty":-6.410602,"median":-5.90231,"eighty":-4.84735,"marketCap":477707444},{"date":"2024-05-17","current":-6.653707,"twenty":-6.497802,"median":-5.932845,"eighty":-4.860193,"marketCap":461893680},{"date":"2024-05-24","current":-7.346604,"twenty":-6.546981,"median":-6.018356,"eighty":-4.875444,"marketCap":509993878},{"date":"2024-05-31","current":-7.617118,"twenty":-6.584345,"median":-6.028342,"eighty":-4.885879,"marketCap":528772723},{"date":"2024-06-07","current":-8.28154,"twenty":-6.629029,"median":-6.03658,"eighty":-4.908353,"marketCap":574896200},{"date":"2024-06-14","current":-8.903248,"twenty":-6.66298,"median":-6.072489,"eighty":-4.908353,"marketCap":618054597},{"date":"2024-06-21","current":-7.441521,"twenty":-6.711656,"median":-6.103378,"eighty":-4.917985,"marketCap":516582946},{"date":"2024-06-28","current":-7.05236,"twenty":-6.714848,"median":-6.103378,"eighty":-4.921032,"marketCap":489567767},{"date":"2024-07-05","current":-7.066597,"twenty":-6.782675,"median":-6.120366,"eighty":-4.923587,"marketCap":490556127},{"date":"2024-07-12","current":-8.276794,"twenty":-6.842522,"median":-6.15029,"eighty":-4.991251,"marketCap":574566747},{"date":"2024-07-15","current":-8.352728,"twenty":-6.873712,"median":-6.156275,"eighty":-4.995541,"marketCap":579838001},{"date":"2024-08-02","current":-6.198104,"twenty":-6.865914,"median":-6.161186,"eighty":-4.999831,"marketCap":430266153},{"date":"2024-08-09","current":-5.54792,"twenty":-6.840926,"median":-6.144305,"eighty":-5.014306,"marketCap":385131036},{"date":"2024-08-16","current":-5.180835,"twenty":-6.826318,"median":-6.112265,"eighty":-5.010821,"marketCap":400038148},{"date":"2024-08-23","current":-5.215088,"twenty":-6.797868,"median":-6.103378,"eighty":-5.014306,"marketCap":402683028},{"date":"2024-08-30","current":-4.975314,"twenty":-6.782675,"median":-6.066504,"eighty":-4.996865,"marketCap":384168866},{"date":"2024-09-06","current":-4.881117,"twenty":-6.774695,"median":-6.03259,"eighty":-4.924513,"marketCap":376895445},{"date":"2024-09-13","current":-4.22602,"twenty":-6.738787,"median":-6.028084,"eighty":-4.89684,"marketCap":326312109},{"date":"2024-09-20","current":-4.461512,"twenty":-6.721232,"median":-5.996218,"eighty":-4.873838,"marketCap":344495661},{"date":"2024-09-27","current":-3.814978,"twenty":-6.714848,"median":-5.932845,"eighty":-4.83926,"marketCap":294573545},{"date":"2024-10-04","current":-3.900612,"twenty":-6.71405,"median":-5.90231,"eighty":-4.736975,"marketCap":301185746},{"date":"2024-10-11","current":-3.408218,"twenty":-6.71006,"median":-5.876988,"eighty":-4.623769,"marketCap":263165591},{"date":"2024-10-18","current":-3.89633,"twenty":-6.698313,"median":-5.858281,"eighty":-4.466448,"marketCap":300855136},{"date":"2024-10-25","current":-4.238865,"twenty":-6.663872,"median":-5.849059,"eighty":-4.397847,"marketCap":327303939},{"date":"2024-10-31","current":-3.543091,"twenty":-6.66298,"median":-5.819389,"eighty":-4.373941,"marketCap":273579808},{"date":"2024-11-08","current":-3.378247,"twenty":-6.65417,"median":-5.783228,"eighty":-4.26556,"marketCap":260851321},{"date":"2024-11-15","current":-2.970727,"twenty":-6.653707,"median":-5.678921,"eighty":-4.257819,"marketCap":257253067},{"date":"2024-11-22","current":-2.367417,"twenty":-6.629978,"median":-5.544882,"eighty":-4.208893,"marketCap":205008871},{"date":"2024-11-29","current":-3.142556,"twenty":-6.626181,"median":-5.512207,"eighty":-4.166207,"marketCap":272132743},{"date":"2024-12-06","current":-2.703438,"twenty":-6.607553,"median":-5.450079,"eighty":-4.100138,"marketCap":234106904},{"date":"2024-12-13","current":-2.72253,"twenty":-6.599941,"median":-5.414849,"eighty":-4.066934,"marketCap":235760202},{"date":"2024-12-20","current":-2.306323,"twenty":-6.589568,"median":-5.281597,"eighty":-3.914314,"marketCap":199718319},{"date":"2024-12-27","current":-2.588885,"twenty":-6.578686,"median":-5.241463,"eighty":-3.893837,"marketCap":224187120},{"date":"2025-01-03","current":-2.546883,"twenty":-6.570706,"median":-5.215088,"eighty":-3.826967,"marketCap":220549866},{"date":"2025-01-10","current":-2.604159,"twenty":-6.564766,"median":-5.210806,"eighty":-3.754178,"marketCap":225509758},{"date":"2025-01-17","current":-1.981757,"twenty":-6.550955,"median":-5.17013,"eighty":-3.659982,"marketCap":171612264},{"date":"2025-01-24","current":-2.142882,"twenty":-6.53506,"median":-5.110187,"eighty":-3.528106,"marketCap":185565027},{"date":"2025-01-31","current":-2.005371,"twenty":-6.527327,"median":-5.031968,"eighty":-3.425345,"marketCap":173657111},{"date":"2025-02-07","current":-2.070307,"twenty":-6.515357,"median":-5.011134,"eighty":-3.395373,"marketCap":179280293},{"date":"2025-02-14","current":-1.611936,"twenty":-6.499398,"median":-4.991251,"eighty":-3.192195,"marketCap":139587239},{"date":"2025-02-21","current":-1.539361,"twenty":-6.496206,"median":-4.928215,"eighty":-3.10819,"marketCap":133302506},{"date":"2025-02-28","current":-1.142107,"twenty":-6.453914,"median":-4.914373,"eighty":-2.892068,"marketCap":98901859},{"date":"2025-03-07","current":-1.073351,"twenty":-6.437026,"median":-4.893962,"eighty":-2.779043,"marketCap":92947901},{"date":"2025-03-14","current":-1.134467,"twenty":-6.376035,"median":-4.880688,"eighty":-2.703438,"marketCap":98240308},{"date":"2025-03-21","current":-1.027514,"twenty":-6.356851,"median":-4.852166,"eighty":-2.601104,"marketCap":88978596},{"date":"2025-03-28","current":-1.387527,"twenty":-6.34619,"median":-4.840506,"eighty":-2.545356,"marketCap":136439657},{"date":"2025-04-04","current":-0.891258,"twenty":-6.338037,"median":-4.795483,"eighty":-2.464405,"marketCap":87640072},{"date":"2025-04-11","current":-0.732587,"twenty":-6.311324,"median":-4.74555,"eighty":-2.42393,"marketCap":72037483},{"date":"2025-04-17","current":-0.769723,"twenty":-6.30019,"median":-4.649906,"eighty":-2.355198,"marketCap":75689153}],"updateTime":1745232586807}}}